Invest, Partner and Network with the Most Promising Early- to
Late-Stage Medical Technology Companies and the Biggest Deal
Makers in the Medtech Business Development and Investment Communities
from Both Sides of the Atlantic
For
more information, please contact Kristy Grimes at 480-985-9512,
888-202-5939 toll-free in the U.S., or e-mail in3@windhover.com
Investment-in-Innovation (In3) conferences are the premier forums worldwide for
discerning senior executives in the medical device, diagnostics, biotech, and
pharmaceutical business development and investment communities to meet and
screen promising medical technology companies in need of funding, acquisition
and/or strategic partnership, and to network with key decision makers in the
industry. Click below to see a video describing why you should attend IN3 conferences:
In3 Europe - Paris ’09 is Medtech Insight and FDC-Windhover’s
34th In3 event – find out for yourself why these
first-rate events are considered the most important venue
of their kind for key investors from around the world
interested in the medical device space.
Program
Benefits:
Hear presentations from 30+ promising early- to late-stage
device companies from around the globe, each followed
by one-on-one meetings in private breakout rooms
Network
with 150+ key deal makers in the device and investment
communities from both sides of the Atlantic
Gain valuable, actionable insight with plenary sessions
by device industry thought leaders sharing their in-the-trenches
experiences in building, funding and selling their companies
Learn
from timely, informative and interactive panel discussions/case
studies examining the hottest issues impacting medical
device innovation and investment in the U.S., Europe,
and other regions
Table-top exhibits and product prototypes by presenting
companies during a networking reception
Workshops for start-up companies
…
and much, much more!
Presentations
from our hand-selected group of cutting-edge early- to
late-stage companies will encompass a wide variety of
high-growth device sectors, including:
Cardiovascular Therapeutics and Diagnostics
Diagnostics
Drug
Delivery
Imaging
and Image-Guided Surgery
Minimally Invasive Surgery
Nanotechnology
Neurostimulation
Oncology
Orthopedics
and Spine
Peripheral
Vascular
Stem
Cells
Stroke
Management
Tissue
Engineering
Wound
Management
...
to mention only a few.
Advisory Board
Jeffrey
Barnes
General Partner
Oxford Bioscience Partners
Annette
Campbell-White
Senior Managing Member MedVenture Associates
Michael
Carusi
General Partner
Advanced Technology Ventures
Luke
Evnin
General Partner
MPM Capital
Richard
M. Ferrari
Managing Director
DeNovo Ventures
William
T. Harrington
Partner
Three Arch Partners
Ross
A. Jaffe
Managing Director
Versant Ventures
Ellen
Koskinas
Partner
InterWest Partners
Josh
Makower
Venture Partner
NEA
John
Maroney
General Partner
Delphi Ventures
Allan May Chairman, Founder
Life Science Angels
Managing Director
Emergent Medical Partner
David
Milne
Managing Partner
SV Life Science Advisers
Trevor
J. Moody
Partner
Frazier Healthcare Ventures
AirInSpace (First-Time Presenter) Montigny Le Bretonneux, France
Company description coming soon.
Anteis SA (First-Time Presenter) Geneva, Switzerland
Innovative injectable medical devices based on biopolymer transformation.
Arterial Remodeling Technologies (ART) Noisy le Roi, France
ART has developed Biodegradable peripheral and coronary polymer stents that promote the natural remodelling of the injured artery after angioplasty.
BBS - Bioactive Bone Substitutes Ltd. Oy (First-Time Presenter) Oulu, Finland
Specializing in innovative therapeutic substances for bone regeneration.
Cardio³ Biosciences SA Braine L'Alleud, Belgium
A leading edge company, founded in 2007 and active in the field of regenerative therapies for the treatment of heart failure.
Cardiola, Ltd. Winterthur, Switzerland
Non-invasive Chronic Heart Failure treatment device using Muscular Counter Pulsation (MCP). The m.pulse device is poised for at home treatment, has received CE clearance and the company is currently ramping up sales and marketing activities.
Facet Solutions Hopkinton, MA
ACADIA™ Facet Replacement System first anatomic facet reconstruction device designed to provide patients with lumbar spinal stenosis and facet degeneration - A motion preservation alternative to fusion.
iiTech B.V. (First-Time Presenter) Amsterdam, The Netherlands
Precision stapling devices enabling minimally invasive vascular connections, especially for Coronary Artery Bypass Graft (CABG) surgery.
Intelligent Medical Implants (IMI), AG Zug, Switzerland
Develop and market an intelligent retinal implant system for degenerative retinal disorders such as Retinitis Pigmentosa or Macular Degeneration.
Invendo Medical GmbH Kissing, Germany
Developed the only next-generation disposable colonoscope incorporating diagnostic and therapeutic capabilities allowing for a potentially sedation-less treatment.
isonic Medical (First-Time Presenter) Paris, France
isonic Medical is developing devices for ophthalmology and refractive surgery like a non-contact tonometer for Homecare monitoring of intra ocular pressure.
Lifenova Biomedical SA (First-Time Presenter) San Sebastian, Spain
Clinically proved surface technology improving the osseointegration of load bearing, e.g. dental, implants.
Our company specializes in RFID (Radio Frequency ID). Our solution includes the world smallest passive and implantable tag.
Medical Device Works (First-Time Presenter) Brussells, Belgium
The only set of catheters for percutaneous isolation of an organ (liver) and local delivery of (any) high dosage chemotherapy for treatment of organ cancer.
mNemoScience GmbH Aachen, Germany
Biocompatible shape memory polymers (BIO-SMP) which can be programmed to change shapes and rigidity when an initiating stimulus, such as e.g. change in temperature, is applied.
MTM Laboratories Westborough, MA
Biomarkers for the screening and diagnosis of cancers; initial focus is on Cervical Cancer.
Nanobiotix Paris, France
New treatments for cancer based on the combined application of nanotechnologies and biotechnologies.
NOLabs AB (First-Time Presenter) Helsingborg, Sweden
A medical device company that intends to become the world leader in diabetes neuropathy related pain control.
Photo Dynamic Therapy Vienna, Austria
Clinical hands-on service with non-invasive tumor treatment modality specific to patients’ individual need by intelligent laser light and photon transformer.
PolyMedix, Inc. Radnor, PA
Novel anti-microbial polymeric coatings for devices and implants.
Quanta Fluid Solutions (First-Time Presenter) Warwickshire, United Kingdom
Introducing SelfCare+, a cartridge based portable Haemodialysis Machine designed for patient use at home. Delivers world class clinical performance but only the size of a carry-on suitcase.
Sensile Medical AG (First-Time Presenter) Hägendorf, Switzerland
Nanoliter-based devices for continuous glucose monitoring and micro insulin delivery systems.
Sensimed AG Lausanne, Switzerland
Soft disposable contact lens embedding MEMS and telemetry monitoring intraocular pressure continuously and non-invasively.
superDimension, Inc. Minneapolis, MN
The superDimension system is a bronchial navigation system that provides a minimally invasive pathway to lung lesions for early detection of lung cancer.
Catheter-based systems that will provide very rapid and selective hypothermia to various body organs and locations.
Veryan Medical, Ltd. West Sussex, United Kingdom
Vascular stents and grafts with increased patency by improved flow dynamics, reducing stenosis and restenosis.
Vittamed (First-Time Presenter) Kaunas, Lithuania
Developed breakthrough non-invasive medical device technology for the monitoring of absolute value of intracranial pressure, cerebral blood flow autoregulation and intracranial volumetric waves in patients with traumatic brain injuries and spinal injuries or other intracraniospinal pathologies.
Benefits
of Attending:
Potential acquirers/funding partners will
able to meet and screen over 30 first-rate investment possibilities
in just 1.5 well-orchestrated days, via focused presentations
covering their widely varied technologies, stage of development
and testing, potential markets, management teams, regulatory
timeline, patent protection, competitive strategy, funding
needed, among many other key details, and private break-out
sessions, among many other networking opportunities.
Medical device start-ups
face intense competition for a finite amount of available
capital funding: In3 Europe - Paris ’09 is an ideal
setting for emerging company management teams to meet and
impress potential investors, from many of the heavy-hitting,
top-tier device companies and discerning healthcare investment
firms from around the world.
All attendees will gain a keen understanding
in a short timeframe of the emerging medical technologies
on course to make a distinct impact on the intensely competitive
and evidence-driven worldwide device industry in the next
few years. Register to attend today and get ready to tap into
the many opportunities about to emerge in the medtech space!
We
have a long and strong track record: Over 1500 emerging medical
technology company presenters and over 8000 attendees have participated
at In3 events over the past 8 years. We are very proud that
many young companies have worked their way up the funding ladder
and into the marketplace via the relationships they formed at
In3 events. Click
here for success stories and testimonials from our past
presenters and attendees.
Attendees
will include:
Presidents
CEOs,
CTOs, COOs
Founders,
Chairpersons
Venture
Partners
Managing
Directors
Vice
Presidents/Directors of Business Development, Marketing, New
Technology, Acquisitions, R & D & Sales
Senior
Investment Analysts/Principals/Directors
….
from these types of companies:
Established medical technology companies from around the world
seeking technology through licensing, partnering and acquisition
to broaden or deepen product lines or build sector strength
Venture
capitalists and investment bankers, and
Medical
device, biotech, biopharmaceutical or other company executives
seeking investments or partnerships
The
med device industry is red hot, with the number of deals now
increasing each year, and the European medical device market
is changing and evolving rapidly. In3 Europe - Paris '09 is
a do-not-miss event for anyone interested in the best-of-the-best
emerging medtech companies from around the globe: we are expecting
a record number of participants, from both the buy and sell
side – hurry and secure your spot today!
Panel Discussion: Trends in European Dealmaking and Investing
Several panelists provide unconventional wisdom on the issues faced by today's medical device players, big and small - from identifying hot clinical areas to understanding the changing funding environment to assessing the current state of M&A and IPO's, as well as looking at market adoption trends and evolving device business models in Europe.
Panelists: David Cassak, Managing Partner, Windhover Information (moderator) Antoine Papiernik, Managing Partner, Sofinnova Partners Dr. Thierry Chignon, Partner, Matignon Investissement & Gestic Ruti Alon, General Partner, Pitango Venture Capital Timothy Haines, Partner, Abingworth Management Ltd.
10:00 - 10:05 AM
Moderator
10:05 - 10:15 AM
PolyMedix, Inc.
10:15 - 10:25 AM
NOLabs AB
10:25 - 10:35 AM
ThermopeutiX, Inc.
10:35 - 10:45 AM
Reserved
10:45 - 10:55 AM
Nanobiotix
10:55 - 11:25 AM
Morning Break Miles Davis Foyer
11:25 - 11:30 AM
Moderator
11:30 - 11:40 AM
MTM Laboratories
11:40 - 11:50 AM
Cardio³ BioSciences SA
11:50 - 12:00 PM
Cardiola, Ltd.
12:00 - 12:10 PM
Lifenova Biomedical, SA
12:10 - 12:20 PM
Invendo Medical GmbH
12:20 - 12:30 PM
iiTech B.V.
12:30 - 1:30 PM
Lunch
1:30 - 1:35 AM
Moderator
1:35 - 1:45 PM
Symetis SA
1:45 - 1:55 PM
Vittamed
1:55 - 2:05 PM
Sensile Medical AG
2:05 - 2:15 PM
Quanta Fluid Solutions
2:15 - 2:25 PM
Intelligent Medical Implants (IMI)
2:25 - 2:35 PM
mNemoscience GmbH
2:35 - 2:40 PM
Moderator
2:40 - 2:50 PM
BBS- Bioactive Bone Substitutes Ltd.
2:50 - 3:00 PM
Medical Device Works
3:00 - 3:10 PM
Sensimed AG
3:10 - 3:20 PM
Photo Dynamic Therapy
3:20 - 3:30 PM
Lutronic, Intl.
3:30 - 3:40 PM
Veryan Medical, Ltd.
3:40 - 3:55 PM
Afternoon Break Miles Davis Foyer
3:55 - 4:45 PM
Best Practices and Lessons from the Front Lines: CEOs Talk about Building Successful Companies in Europe Today Several company creators discuss success stories about how they cultivated their business plans, attracted financing, ran their companies, and planned for their exits. Hear the dos and don’ts directly from experienced entrepreneurs on how they were able to achieve their goals. Panelists: Kevin Sidow, CEO, Moximed Tor Peters, Executive Chairman, Occlutech AB Chas Taylor, Chairman, Novate Medical Ltd. Daniel Sullivan, CEO, superDimension, Inc. Stephen McCormack, CEO, Intelligent Medical Implants
4:45 - 6:30 PM
Presenting Company Exhibition/Networking Reception Miles Davis Foyer
April 30, 2009
8:45 - 9:30 AM
Registration Miles Davis Foyer
9:30 - 9:35 AM
Moderator
9:35 - 9:45 AM
Facet Solutions
9:45 - 9:55 AM
Arterial Remodeling Technologies (ART)
9:55 - 10:05 AM
AirInSpace
10:05 - 10:15 AM
Isonic Medical
10:15 - 10:25 AM
Anteis SA
10:25 - 10:35 AM
superDimension, Inc.
10:35 - 10:50 AM
Morning Break Miles Davis Foyer
10:50 - 11:50 AM
State of the Medical Device Industry Address by Medtech Insight/Windhover’s Device Editorial Team
Key discussion highlights include:
• Hot clinical areas - which therapeutic markets attracted the most attention in 2008, and which ones will stay hot in 2009? What new areas of interest will emerge?
• M&A: Identifying the most important deals and deal trends from 2008and what that means for M&A in the year ahead.
• IPOs: The public market remained open for medtech companies in 2008- who were the winners and losers, and will the window remain open in 2009
• Regulatory/legal: A look at important regulatory, reimbursement and legal issues that will play increasingly important roles in device companies' strategies.
• What are some key growth trends for start-ups?
• Where is the funding going?
• How are device stocks performing?
• What are the new financing models?
• How are large companies sustaining growth?
• How are companies structuring and valuing deals?
Panelists:
David Cassak, Managing Director, Devices, FDC Windhover Stephen Levin, Executive Editor, FDC Windhover
11:50 - 12:40 PM
Lunch
*Cancellation
Policy: Cancellation Policy: The last day to cancel
your registration for a refund, minus a $300 processing fee,
is March 30, 2009. After that, you may send another delegate
from your company.
